VolitionRx Ltd
VNRX
55 hedge funds and large institutions have $25M invested in VolitionRx Ltd in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 2 closing their positions.
1,200% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 5
140% more capital invested
Capital invested by funds: $10.4M → $25M (+$14.6M)
77% more funds holding
Funds holding: 31 → 55 (+24)
0.29% more ownership
Funds ownership: 0.41% → 0.7% (+0.29%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.09M |
| 2 |
LIM
Lagoda Investment Management
New York
|
+$1.22M |
| 3 |
State Street
Boston,
Massachusetts
|
+$851K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$535K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$497K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$454K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$451K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$53.4K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$17K |
| 5 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
-$11.9K |
VNRX Hedge Fund Activity: Q2 2020 in Review
55 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2020, worth a combined $25M — up 140% from $10.4M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new VNRX positions and 2 closed out — a net gain of 24 holders — while 15 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $6.09M. The largest seller was Millennium Management, exiting entirely with an estimated $454K sold.
- 55 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2020, up from 31 in Q1 2020.
- Funds reported $25M of VolitionRx Ltd stock for Q2 2020, up 140% quarter-over-quarter.
- 26 funds opened new VolitionRx Ltd positions in Q2 2020 and 2 closed out, a net change of +24 holders.
- The largest VolitionRx Ltd buyer in Q2 2020 was BlackRock, an estimated $6.09M added.
- The largest VolitionRx Ltd seller in Q2 2020 was Millennium Management, an estimated $454K sold.
Based on aggregated 13F filings for Q2 2020.